>ABOUT TAKEDA >Our Management

Our Management

( As of June 26, 2015 )

Board members

Director
Chairman of the Board 

Yasuchika Hasegawa

Representative Director President & CEO

Christophe Weber

Senior Managing Director
Corporate Strategy Officer,
President, Takeda Pharmaceuticals International, Inc. (not continuous presence)

Shinji Honda

 

Director
President, Japan Pharma Business Unit

Masato Iwasaki, Ph.D.

Director 
Chief Medical & Scientific Officer

Andrew Plump, M.D., Ph.D.

Outside Director
Honorary Advisor, JFE Holdings, Inc.

Fumio Sudo

Outside Director
Chairman of the Board,
Mitsubishi Corporation

Yorihiko Kojima

Outside Director
Councilor,
Komatsu Ltd.

Masahiro Sakane

Corporate Auditors

Corporate Auditor

Naohisa Takeda

Corporate Auditor

Yasuhiko Yamanaka

Corporate Auditor

Tsuguoki Fujinuma

Corporate Auditor

Shiro Kuniya

Corporate Officers

Haruhiko Hirate

Corporate Communications & Public Affairs Officer,

Global Head of Public Affairs 

Marc Princen

President, EUCAN Business Unit

Tadao Hirouchi

Head of East Japan Sales, Japan Pharma Business Unit

David Osborne

Global Human Resources Officer

Tetsuyuki Maruyama, Ph.D.

General Manager, Pharmaceutical Research Division

Yoshihiro Nakagawa

Global General Counsel

Christophe Bianchi

President, Global Oncology Business Unit

Rajeev Venkayya

President, Global Vaccine Business Unit

Giles Platford

President, Emerging Markets Business Unit

Thomas Wozniewski

Global Manufacturing and Supply Officer

Gerard Greco

Global Quality Officer

Mwana Lugogo

Global Compliance Officer

Ramona Sequeira

President, US Business Unit